Detalhe da pesquisa
1.
Detection of Measurable Residual Disease Biomarkers in Extracellular Vesicles from Liquid Biopsies of Multiple Myeloma Patients-A Proof of Concept.
Int J Mol Sci
; 23(22)2022 Nov 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36430163
2.
Perspectives on emerging technologies, personalised medicine, and clinical research for cancer control in Latin America and the Caribbean.
Lancet Oncol
; 22(11): e488-e500, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34735818
3.
The basal epithelial marker P-cadherin associates with breast cancer cell populations harboring a glycolytic and acid-resistant phenotype.
BMC Cancer
; 14: 734, 2014 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25269858
4.
P-cadherin functional role is dependent on E-cadherin cellular context: a proof of concept using the breast cancer model.
J Pathol
; 229(5): 705-18, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23180380
5.
Comprehensive Genomic Studies on the Cell Blocks of Pancreatic Cancer.
Diagnostics (Basel)
; 14(9)2024 Apr 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38732320
6.
Epithelial E- and P-cadherins: role and clinical significance in cancer.
Biochim Biophys Acta
; 1826(2): 297-311, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22613680
7.
P-cadherin is coexpressed with CD44 and CD49f and mediates stem cell properties in basal-like breast cancer.
Stem Cells
; 30(5): 854-64, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22389315
8.
p40: a p63 isoform useful for lung cancer diagnosis - a review of the physiological and pathological role of p63.
Acta Cytol
; 57(1): 1-8, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23221041
9.
ICI 182,780 induces P-cadherin overexpression in breast cancer cells through chromatin remodelling at the promoter level: a role for C/EBPbeta in CDH3 gene activation.
Hum Mol Genet
; 19(13): 2554-66, 2010 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20385540
10.
Nottingham Prognostic Index in triple-negative breast cancer: a reliable prognostic tool?
BMC Cancer
; 11: 299, 2011 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21762477
11.
Terminal α2,6-sialylation of epidermal growth factor receptor modulates antibody therapy response of colorectal cancer cells.
Cell Oncol (Dordr)
; 44(4): 835-850, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33847896
12.
Estrogens, MSI and Lynch syndrome-associated tumors.
Biochim Biophys Acta
; 1796(2): 194-200, 2009 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19559756
13.
Monocarboxylate transporter 1 is up-regulated in basal-like breast carcinoma.
Histopathology
; 56(7): 860-7, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20636790
14.
Expression of FOXA1 and GATA-3 in breast cancer: the prognostic significance in hormone receptor-negative tumours.
Breast Cancer Res
; 11(3): R40, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19549328
15.
A [Glyco]biomarker that Predicts Failure to Standard Therapy in Ulcerative Colitis Patients.
J Crohns Colitis
; 13(1): 39-49, 2019 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30239648
16.
The transcription factor FOXO3a is a crucial cellular target of gefitinib (Iressa) in breast cancer cells.
Mol Cancer Ther
; 6(12 Pt 1): 3169-79, 2007 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-18089711
17.
P-cadherin expression in breast cancer: a review.
Breast Cancer Res
; 9(5): 214, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-18001487
18.
P-cadherin overexpression is an indicator of clinical outcome in invasive breast carcinomas and is associated with CDH3 promoter hypomethylation.
Clin Cancer Res
; 11(16): 5869-77, 2005 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16115928
19.
Maspin expression in normal skin and usual cutaneous carcinomas.
Virchows Arch
; 441(6): 551-8, 2002 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-12461611
20.
Naked nuclei revisited: p63 Immunoexpression.
Diagn Cytopathol
; 27(3): 135-8, 2002 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-12203858